Physician profile
Ryan Minnich
NPI 1881653053
$3,873.91
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.44 · 2020: $278 · 2021: $1,113 · 2022: $1,032 · 2023: $959 · 2024: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $694.21 | 2020-2024 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $478.98 | 2020-2023 | Repatha, Otezla, Prolia |
| Astrazeneca Pharmaceuticals Lp | $453.71 | 2020-2024 | Farxiga, Breztri, Lokelma |
| Glaxosmithkline, LLC. | $413.35 | 2020-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $270.38 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Abbvie INC. | $238.10 | 2021-2023 | |
| Pfizer INC. | $222.60 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $199.27 | 2020-2022 | |
| Amarin Pharma, INC. | $151.26 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $143.85 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.49 | 2020-2024 | Synjardy, Jardiance |
| Exact Sciences Corporation | $104.03 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $95.29 | 2021-2024 | Jardiance |
| Collegium Pharmaceutical, INC. | $61.10 | 2021-2023 | Xtampza |
| Xeris Pharmaceuticals, INC. | $41.43 | 2021-2023 | Keveyis |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $35.69 | 2022-2023 | Freestyle Libre 2 |
| Astellas Pharma US INC | $32.40 | 2024 | Veozah |
| Biohaven Pharmaceuticals, INC. | $30.30 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.57 | 2022 | |
| Esperion Therapeutics, INC. | $18.67 | 2021 | |
| Philips North America LLC | $16.56 | 2021 | |
| Eisai INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Minnich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.